HSA — authorised 19 September 1996
- Marketing authorisation holder: CONCORDIA PHARMS INC
- Status: likely_approved
🇸🇬 Nilandron in Singapore
HSA authorised Nilandron on 19 September 1996
Marketing authorisation
Nilandron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Nilandron approved in Singapore?
Yes. HSA authorised it on 19 September 1996.
Who is the marketing authorisation holder for Nilandron in Singapore?
CONCORDIA PHARMS INC holds the Singaporean marketing authorisation.